31 results on '"Santol J"'
Search Results
2. The blood microbiome and its impact on hepatic failure after liver surgery.
3. Glucagon-like peptide-1 and -2: potential regulators of lipid metabolism during liver regeneration.
4. Comparison of the clinical value of LiMAx vs the APRI+ALBI score-an international multicenter study.
5. Development of a platform for prospective testing of MicroRNA based hepatic function evaluation for risk assessment prior to liver operation – the mi-HERO registry.
6. Comparison of the clinical value of LiMAx measurement with APRI+ALBI score calculation – an international multicenter study.
7. Glucagon-like peptide-1 and glucagon-like peptide-2 are potential regulators of lipid metabolism during human liver regeneration.
8. APRI+ALBI score outperforms icg and limax in predicting phlf - an international multicenter study.
9. The Ratio of Activin A and FLRG Allows Prediction of Postoperative Liver Dysfunction in Patients Undergoing Liver Resection.
10. Validation of the APRI+ALBI smart phone application for preoperative risk assessment after liver resection in a routine clinical setting.
11. Intake of Selective Serotonin Re-uptake Inhibitors Modulates Postoperative Outcome after Liver Resection for Malignant Tumors.
12. Influence of Platelet Degranulation on Postoperative Liver Regeneration.
13. PNPLA3 I148M increases hepatic susceptibility to chemotherapy-associated steatohepatitis and affects overall survival.
14. Treatment of interferon in chronic hepatitis C patients with normal ALT: Results of a controlled study
15. Von Willebrand factor antigen as a versatile preoperative marker in patients undergoing liver resection for hepatocellular carcinoma.
16. Investigation of the Relevance of Platelet Alpha Granules for Postoperative Liver Regeneration in a Mouse Model of Partial Hepatectomy.
17. FGF21 serum dynamics are linked with hepatectomy outcomes & its analogue enhances liver regeneration.
18. Pathophysiology of Bile Acids Affects Liver Regeneration in Patients Undergoing Liver Resection.
19. Plasma Metabolomics in Liver Tumor Patients and its Predictive Performance for Postoperative Disease-free Survival Assessment.
20. Resection for liver metastasis of neuroendocrine tumor of unknown primary (NET-UP): a retrospective, single center, comparative study.
21. Von willebrand factor antigen identifies high-risk hepatocellular cancer patients prior to liver resection who might benefit from liver transplantation instead.
22. Osteopontin Affects Oncological Outcome after Liver Resection for Colorectal Metastasis.
23. Prediction of long-term outcome after liver resection based on preoperative evaluation of three MIRS.
24. The impact of single nucleotide polymorphisms on chemotherapy associated steatohepatitis.
25. In human evidence for the critical relevance of serotonin mediated YAP activation during liver regeneration.
26. Preoperative Serum Axl/Gas6 Allow Stratification of Oncological Outcome in Patients Undergoing Liver Resection for Hepatocellular Carcinoma.
27. Von Willebrand Factor Antigen Facilitates Long Term Risk Stratification In Patients Undergoing Liver Resection.
28. Systematic investigations into a proposed mechanistic biomarker panel of liver injury for use in liver resection.
29. Acute overwhelming inflammation as a mechanism driving postoperative liver failure in humans.
30. Incorporation of von Willebrand Factor Improves MELD-Na Based Prediction of Early Mortality on the Waiting List for Liver Transplantation.
31. Serum Axl/Gas6 Allows Prediction Of Oncological Outcome In Patients Suffering From Hepatocellular Carcinoma Undergoing Curative Liver Resection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.